» Articles » PMID: 23049219

Impact of Body Mass Index and Gender on Quality of Life in Patients with Gastroesophageal Reflux Disease

Overview
Specialty Gastroenterology
Date 2012 Oct 11
PMID 23049219
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To investigate the symptom presentation and quality of life in obese Chinese patients with gastroesophageal reflux disease (GERD).

Methods: Data from patients diagnosed with GERD according to the Montreal definition, were collected between January 2009 to March 2010. The enrolled patients were assigned to the normal [body mass index (BMI) < 25 kg/m(2)], overweight (25-30 kg/m(2)), and obese (BMI > 30 kg/m(2)) groups. General demographic data, endoscopic findings, and quality of life of the three groups of patients were analyzed and compared.

Results: Among the 173 enrolled patients, 102, 56 and 15 patients were classified in the normal, overweight, and obese, respectively. There was significantly more erosive esophagitis (73.3% vs 64.3% vs 39.2%, P = 0.002), hiatal hernia (60% vs 33.9% vs 16.7%, P = 0.001), and males (73.3% vs 73.2% vs 32.4%, P = 0.001) in the obese cases. The severity and frequency of heartburn, not acid regurgitation, was positively correlated with BMI, with a significant association in men, but not in women. Obese patients were prone to have low quality of life scores, with obese women having the lowest scores for mental health.

Conclusion: In patients with GERD, obese men had the most severe endoscopic and clinical presentation. Obese women had the poorest mental health.

Citing Articles

RETRACTED: A Phase III Head-to-Head Study to Compare the Efficacy and Safety of Fexuprazan and Esomeprazole in Treating Patients with Erosive Esophagitis.

Jeong Y, Lee B, Han S J Clin Med. 2024; 13(11).

PMID: 38892973 PMC: 11172701. DOI: 10.3390/jcm13113262.


Risk factors and 26-years worldwide prevalence of endoscopic erosive esophagitis from 1997 to 2022: a meta-analysis.

Witarto A, Witarto B, Pramudito S, Ratri L, Wairooy N, Konstantin T Sci Rep. 2023; 13(1):15249.

PMID: 37709957 PMC: 10502104. DOI: 10.1038/s41598-023-42636-7.


Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat?.

Ruaro B, Pozzan R, Confalonieri P, Tavano S, Hughes M, Cerinic M Pharmaceuticals (Basel). 2022; 15(8).

PMID: 36015181 PMC: 9412643. DOI: 10.3390/ph15081033.


Correlation Between Symptom Severity and Health-Related Life Quality of a Population With Gastroesophageal Reflux Disease.

Lee S, Lee T, Lien H, Peng Y, Yeh H, Chang C Gastroenterology Res. 2017; 10(2):78-83.

PMID: 28496527 PMC: 5412539. DOI: 10.14740/gr753w.


Impact of Obesity on a Chinese Population with Erosive Esophagitis and Barrett's Esophagus.

Lee S, Lien H, Lee T, Tung C, Yeh H, Chang C Gut Liver. 2016; 11(3):377-382.

PMID: 27965477 PMC: 5417780. DOI: 10.5009/gnl16211.


References
1.
Mold J, REED L, Davis A, Allen M, Decktor D, Robinson M . Prevalence of gastroesophageal reflux in elderly patients in a primary care setting. Am J Gastroenterol. 1991; 86(8):965-70. View

2.
Ortiz V, Ponce M, Fernandez A, Martinez B, Ponce J, Garrigues V . Value of heartburn for diagnosing gastroesophageal reflux disease in severely obese patients. Obesity (Silver Spring). 2006; 14(4):696-700. DOI: 10.1038/oby.2006.79. View

3.
Revicki D, Wood M, Maton P, Sorensen S . The impact of gastroesophageal reflux disease on health-related quality of life. Am J Med. 1998; 104(3):252-8. DOI: 10.1016/s0002-9343(97)00354-9. View

4.
Madisch A, Weihs C, Schlaud M, Heimann D, Meyer H, Hotz J . [The Body-Mass-Index (BMI) has no impact on the frequency of typical reflux symptoms -- results of a nationwide telephone-based informing campaign in Germany]. Zentralbl Chir. 2003; 127(12):1064-7. DOI: 10.1055/s-2002-36464. View

5.
Maddox A, Horowitz M, Wishart J, Collins P . Gastric and oesophageal emptying in obesity. Scand J Gastroenterol. 1989; 24(5):593-8. DOI: 10.3109/00365528909093095. View